Adverse health outcomes in women exposed in utero to diethylstilbestrol

New England Journal of Medicine

Volumn 365, Issue 14, 2011, Pages 1304-1314

  Hoover, Robert N ^a   Hyer, Marianne ^b   Pfeiffer, Ruth M ^a   Adam, Ervin ^d   Bond, Brian ^f   Cheville, Andrea L ⁱ   Colton, Theodore ^g   Hartge, Patricia ^a   Hatch, Elizabeth E ^g   Herbst, Arthur L ^j   Karlan, Beth Y ^k   Kaufman, Raymond ^e   Noller, Kenneth L ^l   Palmer, Julie R ^h   Robboy, Stanley J ^m   Saal, Robert C ^c   Strohsnitter, William ^f   Titus Ernstoff, Linda ⁿ   Troisi, Rebecca ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c WESTAT   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e Methodist Hospital   (United States)

^f TUFTS MEDICAL CENTER   (United States)

^g BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^h BOSTON UNIVERSITY   (United States)

ⁱ MAYO CLINIC   (United States)

^j UNIVERSITY OF CHICAGO   (United States)

^k CEDARS SINAI MEDICAL CENTER   (United States)

^l American Board of Obstetrics and Gynecology   (United States)

^m DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁿ DARTMOUTH MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DRUG MEGADOSE; EARLY MENOPAUSE; ECTOPIC PREGNANCY; FEMALE; FOLLOW UP; HIGH RISK PREGNANCY; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL EXPOSURE; PRIORITY JOURNAL; REPRODUCTION; SECOND TRIMESTER ABORTION; SPONTANEOUS ABORTION; STILLBIRTH; UTERINE CERVIX CARCINOMA IN SITU;

EID: 80053469106     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1013961     Document Type: Article

References (40)

1. Dodds EC, Goldberg L, Lawson W, Robinson R. Estrogenic activity of certain synthetic compounds. Nature 1938;141:247-8.
2. Smith OW. Diethylstilbestrol in the prevention and treatment of complications of pregnancy. Am J Obstet Gynecol 1948; 56:821-34.
3. Ferguson JH. Effect of stilbestrol on pregnancy compared to the effect of a placebo. Am J Obstet Gynecol 1953;65:592-601.
4. Dieckmann WJ, Davis ME, Rynkiewicz LM, Pottinger RE. Does the administration of diethylstilbestrol during pregnancy have therapeutic value? Am J Obstet Gynecol 1953;66:1062-81.
5. Swyer GIM, Law RG. An evaluation of the prophylactic ante-natal use of stilboestrol: preliminary report. J Endocrinol 1953;10:vi-vii.
6. The use of hormones in the management of pregnancy in diabetics. Lancet 1955;269:833-6.
7. Herbst AL, Scully RE. Adenocarcinoma of the vagina in adolescence: a report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer 1970;25:745-57.
8. Ulfelder H. The stilbestrol disorders in historical perspective. Cancer 1980;45:3008-11. (Pubitemid 11191748)
9. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284:878-81.
10. Herbst AL, Kurman RJ, Scully RE. Vaginal and cervical abnormalities after exposure to stilbestrol in utero. Obstet Gynecol 1972;40:287-98.
11. Barnes AB, Colton T, Gundersen J, et al. Fertility and outcome of pregnancy in women exposed in utero to diethylstilbestrol. N Engl J Med 1980;302:609-13. (Pubitemid 10073410)
12. Bibbo M, Gill WB, Azizi F, et al. Follow-up study of male and female offspring of DES-exposed mothers. Obstet Gynecol 1977;49:1-8. (Pubitemid 8034053)
13. Labarthe D, Adam E, Noller KL, et al. Design and preliminary observations of National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol 1978;51:453-8. (Pubitemid 8355293)
14. Greenberg ER, Barnes AB, Resseguie L, et al. Breast cancer in mothers given diethylstilbestrol in pregnancy. N Engl J Med 1984;311:1393-8. (Pubitemid 15175270)
15. Kaufman RH, Adam E, Hatch EE, et al. Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring. Obstet Gynecol 2000;96:483-9.
16. Palmer JR, Hatch EE, Rao RS, et al. Infertility among women exposed prenatally to diethylstilbestrol. Am J Epidemiol 2001;154:316-21. (Pubitemid 32756627)
17. Hatch EE, Herbst AL, Hoover RN, et al. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). Cancer Causes Control 2001;12:837-45. (Pubitemid 33010622)
18. Hatch EE, Troisi R, Wise LA, et al. Age at natural menopause in women exposed to diethylstilbestrol in utero. Am J Epidemiol 2006;164:682-8. (Pubitemid 44453497)
19. Palmer JR, Wise LA, Hatch EE, et al. Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006;15:1509-14. (Pubitemid 44299324)
20. Troisi R, Titus-Ernstoff L, Hyer M, et al. Preeclampsia risk in women exposed prenatally to diethylstilbestrol (DES). Obstet Gynecol 2007;110:113-20. (Pubitemid 47015709)
21. Harlow SD, Linet MS. Agreement between questionnaire data and medical records: the evidence for accuracy of recall. Am J Epidemiol 1989;129:233-48. (Pubitemid 19046991)
22. Olson JE, Shu XO, Ross JA, Pendergrass T, Robison LL. Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children's Cancer Group. Am J Epidemiol 1997;145:58-67. (Pubitemid 27009058)
23. Tilley BC, Barnes AB, Bergstralh E, et al. A comparison of pregnancy history recall and medical records: implications for retrospective studies. Am J Epidemiol 1985; 121:269-81. (Pubitemid 15158538)
24. Cox DR, Oakes RA. Analysis of survival data. London: Chapman and Hall, 1984.
25. Breslow NE. Discussion of Professor Cox's paper. J R Stat Soc B 1972;34:216-7.
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. (Pubitemid 17189972)
27. SAS/STAT 9.2 users' guide. Cary, NC: SAS Institute, 2008.
28. Robboy SJ, Kaufman RH, Prat J, et al. Pathologic findings in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol 1979;53:309-17. (Pubitemid 9110953)
29. Herbst AL, Poskanzer D, Robby SJ, Friedlander L, Scully RE. Prenatal exposure to stilbestrol: a prospective comparison of exposed female offspring with unexposed controls. N Engl J Med 1975;292:334-9.
30. O'Brien PC, Noller KL, Robboy SJ, et al. Vaginal epithelial changes in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol 1979;53:300-8. (Pubitemid 9110952)
31. Troisi R, Hatch EE, Titus-Ernstoff L, et al. Cancer risk in women prenatally exposed to diethylstilbestrol. Int J Cancer 2007;121:356-60. (Pubitemid 46917705)
32. Titus-Ernstoff L, Perez K, Hatch EE, et al. Psychosexual characteristics of men and women exposed prenatally to diethylstilbestrol. Epidemiology 2003;14:155-60. (Pubitemid 40417101)
33. Baird DD, Newbold R. Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development. Reprod Toxicol 2005;20:81-4. (Pubitemid 40459654)
34. D'Aloisio AA, Baird DD, DeRoo LA, Sandler DP. Association of intrauterine and early-life exposures with diagnosis of uterine leiomyomata by 35 years of age in the Sister Study. Environ Health Perspect 2010;118:375-81. [Erratum, Environ Health Perspect 2010;118:380.]
35. O'Reilly EJ, Mirzaei F, Forman MR, Ascherio A. Diethylstilbestrol exposure in utero and depression in women. Am J Epidemiol 2010;171:876-82.
36. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Michels KB, Hunter DJ. In utero exposures and the incidence of endometriosis. Fertil Steril 2004;82:1501-8. (Pubitemid 39611373)
37. Wise LA, Palmer JR, Rowlings K, et al. Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure. Obstet Gynecol 2005;105:167-73. (Pubitemid 40189928)
38. Verloop J, Van Leeuwen FE, Helmerhorst TJM, Van Boven HH, Rookus MA. Cancer risk in DES daughters. Cancer Causes Control 2010;21:999-1007.
39. Diamanti-Kandarakis E, Bourguigon JP, Giudice LC, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 2009;30:293-342.
40. Tilghman SL, Nierth-Simpson EN, Wallace R, Burrow ME, McLachlan JA. Environmental hormones: multiple pathways for response may lead to multiple disease outcomes. Steroids 2010;75:520-3.